Publication Name	World Journal of Gastroenterology
Manuscript ID	17343
Country	Türkiye

Received	2015-03-02 08:22
Peer-Review Started	2015-03-04 17:12
To Make the First Decision	2015-04-13 16:36
Return for Revision	2015-04-16 11:06
Revised	2015-04-21 18:05
Second Decision	2015-06-03 08:06
Accepted by Journal Editor-in-Chief	2015-06-03 17:27
Accepted by Company Editor-in-Chief	2015-06-10 16:29
Articles in Press	2015-06-10 16:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-06 14:31
Publish the Manuscript Online	2015-09-18 10:11

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin’s lymphoma
Manuscript Source	Unsolicited Manuscript
All Author List	Hasan Tahsin Gozdas and Erkan Arpaci
Funding Agency and Grant Number
Corresponding Author	Dr. Hasan Tahsin Gozdas, Department of Infectious Diseases and Clinical Microbiology, Dr. Münif İslamoğlu Kastamonu State Hospital, 37100 Kastamonu, Turkey. dr.htgozdas@yahoo.com.tr
Key Words	Immunochemotherapy; Hepatitis B reactivation; Antiviral prophylaxis; Lamivudine; Entecavir
Core Tip	Lamivudine is used for the prevention of hepatitis B virus (HBV) reactivation in patients receiving immunochemotherapy. Following cessation of lamivudine prophylaxis, HBV reactivation can be observed because of insufficient duration of prophylaxis. If HBV DNA is moderately elevated at that moment, prophylaxis may be continued with lamivudine instead of entecavir.
Publish Date	2015-09-18 10:11
Citation	Gozdas HT, Arpaci E. Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin’s lymphoma. World J Gastroenterol 2015; 21(35): 10251-10252
URL	http://www.wjgnet.com/1007-9327/full/v21/i35/10251.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i35.10251

Full Article (PDF)	WJG-21-10251.pdf
Full Article (Word)	WJG-21-10251.doc
Manuscript File	17343-Review.doc
Answering Reviewers	17343-Answering reviewers.pdf
Audio Core Tip	17343-Audio core tip.mp3
Copyright License Agreement	17343-Copyright assignment.pdf
Peer-review Report	17343-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	17343-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	17343-Scientific misconduct check.pdf
Scientific Editor Work List	17343-Scientific editor work list.pdf